Solventum Corporation (SOLV) Earnings Call Transcripts

Solventum Corporation's Latest Earnings Call - Q2 FY2026

In the second quarter of fiscal year 2026, Solventum Corporation (SOLV:US) reported revenues of $2.2 billion, reflecting a 9.5% increase on an organic basis, driven by strong performance across all segments. Earnings per share (EPS) came in at $2.55, surpassing expectations due to advanced orders related to the ERP cutover and a one-time tariff refund. Management raised guidance for organic sales growth to 2.5%-3% and EPS to $7.10-$7.20, indicating confidence in achieving long-term growth targets earlier than anticipated.

Reported metrics

Guidance from management

Management raised 2026 organic sales growth guidance to 2.5%-3% and EPS guidance to $7.10-$7.20, reflecting confidence in achieving long-term growth targets earlier than expected.

What management said

Great. I just want to make sure on that last question, Jason, and it's funny, Wayde and I are kind of laughing across the desk because we were questioning whether HIS would be the first one or not. And then we were trying to say what would the sub-question be, you did most of them. On that last question, though, can you just provide context? I just want to make sure I got that right.

Yes. We appreciate it. We're paying a lot of attention to what we're hearing out there. There's no question that there's been a lot of noise. And there's been conflicting information that some people are saying that they're seeing that demand wane and others are saying they're not seeing it at all. And we're in that camp. We're not actually seeing right now, at least at this point, any softness in the procedures or t...

What analysts pressed on

Analysts expressed concerns regarding the potential EPS dilution from the HIS separation and the impact of advanced orders on future quarters. There were also questions about market demand trends and how the company plans to manage its capital allocation post-separation.

Main topics on the call

• Strong Financial Performance — Solventum delivered a solid quarter with organic growth of 9.5% and EPS of $2.55, which includes a $0.34 contribution from advanced orders. Management noted, "We delivered across the board," highlighting robust execution...
• ERP Cutover and Advanced Orders — The quarter's results included approximately $125 million in advanced orders due to the ERP cutover, which is expected to reverse in Q3. Wayde McMillan stated, "We are managing through planned temporary advanced ordering...
• Health Information Systems (HIS) Separation — Management announced the advancement of the HIS business separation, aiming to unlock shareholder value. Bryan Hanson emphasized, "We see significant opportunity... to maximize it, we're going to have to see a different ...
• Portfolio Optimization and Acquisitions — The company is focusing on portfolio optimization, including the successful integration of Acera, which grew 48% year-over-year. Hanson noted, "This is the M&A playbook, a differentiated technology in a space we know acc...

Read the full Solventum Corporation transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 21 Solventum Corporation earnings call transcripts on record, spanning May 15, 2024 to August 5, 2026. Based on this history, Solventum Corporation reports quarterly. The most recent call on file is dated August 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

SOLV

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

21

First call

May 15, 2024

Most recent

August 5, 2026

Reporting cadence

quarterly